What are the potential causes of a patient presenting with leukopenia (low White Blood Cell (WBC) count) and neutropenia (low absolute neutrophils)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 21, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Low WBC and Low Absolute Neutrophils

Leukopenia with neutropenia results from either decreased bone marrow production, increased peripheral destruction, or redistribution of neutrophils, with the most common causes being chemotherapy-induced bone marrow suppression, medications (especially antibiotics), infections, autoimmune disorders, and hematologic malignancies. 1, 2

Primary Etiologic Categories

Decreased Bone Marrow Production

  • Chemotherapy and cytotoxic agents are the most frequent cause, with standard-dose chemotherapy causing febrile neutropenia in 10-57% of patients and AML induction/consolidation causing it in 35-48% 1
  • Hematologic malignancies including chronic lymphocytic leukemia (CLL), hairy cell leukemia, and acute leukemias cause marrow infiltration and failure 3, 1
  • Stem cell transplantation (both autologous and allogeneic) regularly causes profound neutropenia 1
  • Megaloblastic anemia from vitamin B12 or folate deficiency impairs myeloid cell maturation 4

Increased Peripheral Destruction or Utilization

  • Severe infections consume neutrophils faster than they can be produced, with bacterial sepsis being particularly common 3, 5, 4
  • Autoimmune neutropenia from antibodies directed against neutrophils causes accelerated destruction 2, 4
  • Hypersplenism sequesters and destroys neutrophils in an enlarged spleen 4

Medication-Induced Neutropenia

  • Beta-lactam antibiotics (especially penicillinase-resistant penicillins, ticarcillin, moxalactam, cefoxitin) cause immunologic destruction of peripheral neutrophils, particularly at high doses (≥150 mg/kg/day in pediatrics) 6
  • Purine analogs (cladribine, pentostatin) used in CLL and hairy cell leukemia produce profound and prolonged immunosuppression lasting over a year 3
  • Anti-CD20 monoclonal antibodies (rituximab, obinutuzumab) reduce both B cells and granulocytes 3
  • Recovery typically occurs within days after discontinuing the offending medication 6

Viral Infections

  • Acute viral infections (EBV, CMV, HSV, VZV, respiratory viruses) cause transient neutropenia with relative or absolute reduction in neutrophils 7
  • These typically present with fever, constitutional symptoms, and self-limited course 7

Congenital and Hereditary Disorders

  • Primary neutropenia syndromes are rare but may be hereditary and associated with other developmental defects, particularly in children 5, 4
  • Intrinsic marrow defects cause impaired proliferation and maturation of myeloid progenitor cells 2

Critical Risk Stratification

Severity Classification

  • Mild neutropenia: ANC 1.0-1.5 × 10⁹/L 8
  • Moderate neutropenia: ANC 0.5-1.0 × 10⁹/L 8
  • Severe neutropenia: ANC <0.5 × 10⁹/L, with greatest infection risk when ANC <100/mcL 3, 1, 8

Duration Matters

  • Prolonged neutropenia (>7 days) significantly increases infection risk and mortality 3, 1, 8
  • The rate of neutrophil count decline correlates with bone marrow reserve and infection severity 3, 1

Essential Diagnostic Workup

Immediate evaluation should include:

  • Complete blood count with differential to calculate absolute neutrophil count 8, 7
  • Peripheral blood smear examination to assess cell morphology 5
  • Comprehensive medication review, particularly recent antibiotics and chemotherapy 2, 6
  • Assessment for fever (>38.5°C for >1 hour), which constitutes a medical emergency when ANC <0.5 × 10⁹/L 1, 8, 7

Additional testing based on clinical context:

  • Bone marrow aspirate/biopsy with cytogenetics if etiology unclear or malignancy suspected 5, 2
  • Viral serologies (EBV, CMV, HSV, VZV) if acute infection suspected 7
  • Serum immunoglobulins and protein electrophoresis if recurrent infections present 7
  • Blood cultures, urine cultures, and chest X-ray before initiating antibiotics in febrile patients 8

Critical Clinical Pitfalls

Signs and symptoms of infection are often absent or muted in severely neutropenic patients due to lack of inflammatory cells, leaving patients with infections but without typical cellulitis, pulmonary infiltrates, CSF pleocytosis, or pyuria 3. Fever remains the primary early indicator 3.

Approximately 50-60% of febrile neutropenic patients have an established or occult infection, with 10-20% developing bloodstream infections when ANC <100/mcL 3, 1. Primary infection sites include the alimentary tract (mouth, pharynx, esophagus, colon, rectum), sinuses, lungs, and skin 3.

Gram-positive organisms (coagulase-negative staphylococci, S. aureus, viridans streptococci, enterococci) and gram-negative organisms (E. coli, Klebsiella, Enterobacter, P. aeruginosa) are the most common initial pathogens 3, 1. Antibiotic-resistant bacteria, fungi (especially Candida and Aspergillus), and viruses cause subsequent infections 3.

Empirical broad-spectrum antibiotics must be initiated within 2 hours of fever presentation in neutropenic patients, as earlier administration is associated with fewer complications 1, 8. For severe neutropenia (ANC <0.5 × 10⁹/L), implement prophylactic fluoroquinolone therapy in high-risk patients 8.

References

Guideline

Febrile Neutropenia and Thrombocytopenia in Cancer Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hematologic Conditions: Leukopenia.

FP essentials, 2019

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The etiology and management of leukopenia.

Canadian family physician Medecin de famille canadien, 1984

Research

Neutropenia: causes and consequences.

Seminars in hematology, 2002

Guideline

Neutropenia and Lymphocytosis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Neutropenia Management and Classification

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the management approach for a patient with leukopenia, specifically neutropenia, and how can the risk of infections be mitigated?
What are the management strategies for a patient with low neutrophil (absolute neutrophil count) and low white blood cell (WBC) count?
What is the cause of a 16-year-old male's sleep disturbances, morning bloating, fatigue, pallor, and periorbital darkness, with lab results indicating neutrophilia, leukopenia, and elevated Red Cell Distribution Width (RDW)?
What is the assessment and management for a patient with severe neutropenia and leukopenia?
What is the management approach for a patient with neutropenia and leukocytosis?
Can a critically ill patient with a chest tube (thoracostomy tube) and no pneumothorax, who is intubated and has urinary retention (high pee pressure), develop subacute subcutaneous emphysema around the face and chest?
Is an isolated monocytosis (mono count of 1.1, where normal is 1 or less) in an otherwise normal Complete Blood Count (CBC) a concern?
How to manage a patient with hypoxemic respiratory failure, as indicated by an arterial blood gas (ABG) showing alkalosis (pH 7.51), normocapnia (pCO2 41), hypoxemia (pO2 47), elevated bicarbonate (HCO3 33), low oxygen saturation (86%), and a p/f ratio of 135, on 35% fraction of inspired oxygen (FiO2)?
What are the risks of hypercobalaminemia (elevated vitamin B12 levels above 1000) in patients with pre-existing medical conditions, such as cardiovascular disease or neurological disorders?
What is the maximum recommended dose of Lexapro (escitalopram) for elderly patients 65 years or older with impaired renal function?
How to manage a patient with a vitamin B12 level of 157?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.